Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 304 publications
Burden of fatigue or pruritus in patients with primary biliary cholangitis: a United States matched case-control study.
Journal: Journal of comparative effectiveness research
Published: August 12, 2026
Real-world treatment patterns and clinical outcomes of patients with primary biliary cholangitis in the United States.
Journal: Journal of comparative effectiveness research
Published: August 12, 2026
A Review of Therapies for Primary Biliary Cholangitis.
Journal: Gastroenterology & hepatology
Published: July 02, 2026
Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE-related hemochromatosis.
Journal: Clinical hematology international
Published: June 26, 2026
Reply: Iron deposition in steatotic liver disease-A matter of compartment, but can it be a target for treatment?
Journal: Hepatology communications
Published: March 02, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.
Journal: Nature reviews. Gastroenterology & hepatology
Published: February 19, 2026
Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension.
Journal: Alimentary pharmacology & therapeutics
Published: February 13, 2026
Evolving Concepts of Treatment Targets for PBC: A Global Perspective.
Journal: The American journal of gastroenterology
Published: February 09, 2026
Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.
Journal: Hepatology (Baltimore, Md.)
Published: February 06, 2026
Current and Emerging Approaches for Management of Primary Sclerosing Cholangitis.
Journal: Gastroenterology & hepatology
Published: February 06, 2026
Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic Potential.
Journal: Drug design, development and therapy
Published: January 06, 2026
Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 05, 2025
Last Updated: 09/26/2026